Trachoma

Phase 4 trials (5)

• fluorometholone
• albendazole
• ivermectin
• azithromycin
• tetracycline

Phase 3 trials (1)

• diethylcarbamazine

Phase 2 trials (2)

• permethrin
• 3-[n-butyl-n-acetyl]-aminopropionic acid ethyl ester

Phase 1 trials (1)

• cth522

Other trials (1)

• methylcellulose

Organization Involved with Phase 4 Indications (14)

• National Eye Institute (NEI)
• National Institute of Allergy and Infectious Diseases (NIAID)
• Armauer Hansen Research Institute, Ethiopia
• University of London
• Emory University
• Johns Hopkins University
• University of California, San Francisco
• F.I. Proctor Foundation
• Bill and Melinda Gates Foundation
• The Carter Center
• Bahir Dar Regional Health and Research Laboratory
• Federal Ministry of Health, Ethiopia
• Government of Mozambique
• Le Programme National de Santé Oculaire (PNSO)

Organization Involved with Phase 3 Indications (4)

• Laboratoires Thea
• Lihir Medical Centre
• University of Angers
• Government of Papua New Guinea

Organization Involved with Phase 2 Indications (2)

• Government of Ethiopia
• The Fred Hollows Foundation

Organization Involved with Phase 1 Indications (2)

• Statens Serum Institut
• Imperial College London

Organization Involved with Other Experimental Indications (8)

• University of Pennsylvania
• Centre d'Appui à la lutte contre la Maladie
• National Taiwan University
• Centre National d'Appui à la Lutte contre la Maladie, Mali
• Lions Clubs International Foundation (funding)
• Berhan Public Health and Eye Care Consultancy PLC
• Grarbet Tehadiso Mahber
• International Trachoma Initiative